Gsk Share Discussion Threads

[top tips] 18/4/2017 11:50

ImmuPharma (IMM)

Share price 57p
Market Cap £75m

1) ‘Lupuzor’; for Lupus currently in pivotal Phase 3 trials.
2) All patients now recruited.
3) Headline results expected Q1 2018.
4) Incremental announcements expected throughout 2017.
5) On FDA’s “fast track” “special protocol” route after strong safety and efficacy in Phase 2, so if IMM adheres to same protocol as Phase 2b and delivers positive results, FDA will not request further trial with different endpoints or outcomes.
6) Potential “multi-billion dollar sales”.
7) Currently 100% owned by IMM.
8) Very little competition, with only one other Lupus drug approved in last 50 years - GSK’s Benlysta reached sales over $400m in 2015, with annual sales predicted at $1bn by 2020.
9) IMM’s Lupuzor already demonstrated in Phase IIb that it is safer and more effective than Benlysta.
10) Fully cashed up from £4.1m fund raise in March 2017, enabling it to complete the pivotal Phase 3 trials and progress other pipeline projects.

Northland Capital has a 171p current valuation on IMM.

With the blockbuster sales potential, little competition, good Phase 2 and FDA fast track status, I personally think it could be £7 to £10 if the Phase 2 results are good in Q1 2018.

[bracke] 10/4/2017 17:50

You can't chart (very well) with one indicator. Chartists use several.

[montyhedge] 10/4/2017 15:31

No, where, thats not a chartist. Name one. Your never heard of a rich chartist.
Everyone uses charts like a tool to help you decide, along with fundamentals, but not solely by themselves.

You can't play a round of golf with just a putter, you need the other 13 clubs.

[al101uk] 08/4/2017 22:27

You have now.

[montyhedge] 07/4/2017 20:20

Sorry Brake but never heard of a rich chartist.Charts are just one tool, you would not play golf with just a putter, you need the other 13 clubs.

[essentialinvestor] 07/4/2017 18:56

brake many thanks, much appreciated.

[bracke] 07/4/2017 18:44

Good day EI

I would be looking at the price action relative to the two fib levels I mentioned in my post and the ML and LP (Median Line and Lower Parallel - ie. the lower two diagonal lines). If the share price drops to 1620 I would be looking at the price action at that level and an indication of good support.

Just because the share price dropped to 1620 would not cause an automatic buy, it may find little or no support and continue down further.

Although my trading and investment is based on charts it isn't a simple question of buying or selling at a particular line. It's the action of price at those lines and other indicators.

Sorry I am unable to give you a hard and fast answer but it is worth watching what happens at 1620.

[essentialinvestor] 07/4/2017 16:23

brake,
may I ask if GSK hitS 1620 approx, would you buy?,
appreciate if you would prefer not to answer, TIA.

[bracke] 07/4/2017 15:59

This is the 4 Hour chart which provides a little more detail.

After dropping down to the LP (Lower Parallel) it tracked along it for two candles then attempted to break up but resisted and sent packing at the 23.6% Fib which has been a previous s/r zone. Now has to regroup for another attempt or capitulate and drop to the 38.2% Fib to ascertain if there is support at that zone.

GSK 4 HOUR

[essentialinvestor] 07/4/2017 15:30

Right, have sold my small amount at 1644.7, taking a view we are going
lower here, may be wrong on this, going with a gut call here.
Will look to buy back in further down, if available. Just my own take only,
the share price may do something completely different.

[badtime] 07/4/2017 13:57

EI ..I'd say lower but it's how much lower ..don't hold that many ..no rush to sell (yet) but no rush to add either

[montyhedge] 07/4/2017 13:37

Buying GSK is just like buying a bond, not a growing dividend stock, but you know what you get each year. I bet the GSK bonds pay more.

[montyhedge] 07/4/2017 12:57

Ess
Played Monday and Wednesday, not today.

[essentialinvestor] 07/4/2017 12:49

bt, can't call GSK atm, lower my best guess.

[sicker] 07/4/2017 10:40

My tee time is 14.00 :-)
My tea time is 17.00

[essentialinvestor] 07/4/2017 10:13

monty, you must be heading out on the golf course soon, lovely morning
in Weybridge.

[badtime] 07/4/2017 09:55

Oh yes I remember it

[essentialinvestor] 07/4/2017 09:46

bt, it was the Paul Daniels catchphrase.. I like it, but not a lot.

Never found it funny tbh, but he seemed to like it, a lot.

[badtime] 07/4/2017 09:43

Hmm...I don't see that as a lot....EI....a conservative amount then

[essentialinvestor] 07/4/2017 09:37

lol, yes monty I thought that may be your price ).

You may need some market downside , but who knows.

brake's chart looked nice.

[montyhedge] 07/4/2017 09:26

Essential Yes 1580p, then tuck away. I don't like it when a new CEO comes in, normally they do a kitchen sink job, blame past directors then turn it around after a couple of years. Then say how good they are.

[essentialinvestor] 07/4/2017 09:23

Only have 880 atm.

I like it but not a lot? )

[badtime] 07/4/2017 09:21

Depends what you define as 'a lot' I guess

[essentialinvestor] 07/4/2017 09:12

monty, what price you looking for?. around 1580 at a guess.

[essentialinvestor] 07/4/2017 08:11

If only it was that easy!.